HEADER SIGNALING PROTEIN/IMMUNE SYSTEM 19-OCT-21 7SK9 TITLE CRYO-EM STRUCTURE OF HUMAN ACKR3 IN COMPLEX WITH A SMALL MOLECULE TITLE 2 PARTIAL AGONIST CCX662, AND AN INTRACELLULAR FAB COMPND MOL_ID: 1; COMPND 2 MOLECULE: ATYPICAL CHEMOKINE RECEPTOR 3; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: C-X-C CHEMOKINE RECEPTOR TYPE 7,CXC-R7,CXCR-7,CHEMOKINE COMPND 5 ORPHAN RECEPTOR 1,G-PROTEIN COUPLED RECEPTOR 159,G-PROTEIN COUPLED COMPND 6 RECEPTOR RDC1 HOMOLOG,RDC-1; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: CID24 FAB HEAVY CHAIN; COMPND 10 CHAIN: F; COMPND 11 ENGINEERED: YES; COMPND 12 MOL_ID: 3; COMPND 13 MOLECULE: CID24 FAB LIGHT CHAIN; COMPND 14 CHAIN: E; COMPND 15 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ACKR3, CMKOR1, CXCR7, GPR159, RDC1; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_TAXID: 9606; SOURCE 11 EXPRESSION_SYSTEM: ESCHERICHIA COLI 'BL21-GOLD(DE3)PLYSS AG'; SOURCE 12 EXPRESSION_SYSTEM_TAXID: 866768; SOURCE 13 MOL_ID: 3; SOURCE 14 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 15 ORGANISM_TAXID: 9606; SOURCE 16 EXPRESSION_SYSTEM: ESCHERICHIA COLI 'BL21-GOLD(DE3)PLYSS AG'; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 866768 KEYWDS ATYPICAL CHEMOKINE RECEPTOR, MEMBRANE PROTEIN, SIGNALING PROTEIN, KEYWDS 2 SIGNALING PROTEIN-IMMUNE SYSTEM COMPLEX EXPDTA ELECTRON MICROSCOPY AUTHOR Y.C.YEN,C.T.SCHAFER,M.GUSTAVSSON,T.M.HANDEL,J.J.G.TESMER REVDAT 1 27-JUL-22 7SK9 0 JRNL AUTH Y.C.YEN,C.T.SCHAFER,M.GUSTAVSSON,S.A.EBERLE,P.K.DOMINIK, JRNL AUTH 2 D.DENEKA,P.ZHANG,T.J.SCHALL,A.A.KOSSIAKOFF,J.J.G.TESMER, JRNL AUTH 3 T.M.HANDEL JRNL TITL STRUCTURES OF ATYPICAL CHEMOKINE RECEPTOR 3 REVEAL THE BASIS JRNL TITL 2 FOR ITS PROMISCUITY AND SIGNALING BIAS. JRNL REF SCI ADV V. 8 N8063 2022 JRNL REFN ESSN 2375-2548 JRNL PMID 35857509 JRNL DOI 10.1126/SCIADV.ABN8063 REMARK 2 REMARK 2 RESOLUTION. 3.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : LEGINON, CRYOSPARC, CRYOSPARC, REMARK 3 CRYOSPARC, CRYOSPARC REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.700 REMARK 3 NUMBER OF PARTICLES : 297347 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 7SK9 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB. REMARK 100 THE DEPOSITION ID IS D_1000260447. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : COMPLEX STRUCTURE OF ACKR3 REMARK 245 -CCX662- CID24 REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : 0.20 REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 8.00 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : GATAN K3 (6K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : NULL REMARK 245 MAXIMUM DEFOCUS (NM) : NULL REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : 2.70 REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 5380.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, F, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -1 REMARK 465 ALA A 0 REMARK 465 PRO A 1 REMARK 465 ASP A 2 REMARK 465 LEU A 3 REMARK 465 HIS A 4 REMARK 465 LEU A 5 REMARK 465 PHE A 6 REMARK 465 ASP A 7 REMARK 465 TYR A 8 REMARK 465 SER A 9 REMARK 465 GLU A 10 REMARK 465 PRO A 11 REMARK 465 GLY A 12 REMARK 465 ASN A 13 REMARK 465 PHE A 14 REMARK 465 SER A 15 REMARK 465 ASP A 16 REMARK 465 ILE A 17 REMARK 465 SER A 18 REMARK 465 TRP A 19 REMARK 465 PRO A 20 REMARK 465 CYS A 21 REMARK 465 ASN A 22 REMARK 465 SER A 23 REMARK 465 SER A 24 REMARK 465 ASP A 25 REMARK 465 CYS A 26 REMARK 465 ILE A 27 REMARK 465 VAL A 28 REMARK 465 VAL A 29 REMARK 465 ASP A 30 REMARK 465 THR A 31 REMARK 465 VAL A 32 REMARK 465 MET A 33 REMARK 465 CYS A 34 REMARK 465 PRO A 35 REMARK 465 ASN A 36 REMARK 465 MET A 37 REMARK 465 PRO A 38 REMARK 465 ASN A 39 REMARK 465 THR A 187 REMARK 465 SER A 188 REMARK 465 ALA A 189 REMARK 465 SER A 190 REMARK 465 ASN A 191 REMARK 465 ASN A 192 REMARK 465 GLU A 193 REMARK 465 THR A 194 REMARK 465 PHE A 330 REMARK 465 ILE A 331 REMARK 465 PHE A 332 REMARK 465 LYS A 333 REMARK 465 TYR A 334 REMARK 465 SER A 335 REMARK 465 ALA A 336 REMARK 465 LYS A 337 REMARK 465 THR A 338 REMARK 465 GLY A 339 REMARK 465 LEU A 340 REMARK 465 THR A 341 REMARK 465 LYS A 342 REMARK 465 LEU A 343 REMARK 465 ILE A 344 REMARK 465 ASP A 345 REMARK 465 ALA A 346 REMARK 465 SER A 347 REMARK 465 ARG A 348 REMARK 465 VAL A 349 REMARK 465 SER A 350 REMARK 465 GLU A 351 REMARK 465 THR A 352 REMARK 465 GLU A 353 REMARK 465 TYR A 354 REMARK 465 SER A 355 REMARK 465 ALA A 356 REMARK 465 LEU A 357 REMARK 465 GLU A 358 REMARK 465 GLN A 359 REMARK 465 SER A 360 REMARK 465 THR A 361 REMARK 465 LYS A 362 REMARK 465 GLY A 363 REMARK 465 ARG A 364 REMARK 465 PRO A 365 REMARK 465 LEU A 366 REMARK 465 GLU A 367 REMARK 465 VAL A 368 REMARK 465 LEU A 369 REMARK 465 PHE A 370 REMARK 465 GLN A 371 REMARK 465 GLY A 372 REMARK 465 PRO A 373 REMARK 465 HIS A 374 REMARK 465 HIS A 375 REMARK 465 HIS A 376 REMARK 465 HIS A 377 REMARK 465 HIS A 378 REMARK 465 HIS A 379 REMARK 465 HIS A 380 REMARK 465 HIS A 381 REMARK 465 HIS A 382 REMARK 465 HIS A 383 REMARK 465 ASP A 384 REMARK 465 TYR A 385 REMARK 465 LYS A 386 REMARK 465 ASP A 387 REMARK 465 ASP A 388 REMARK 465 ASP A 389 REMARK 465 ASP A 390 REMARK 465 LYS A 391 REMARK 465 GLU F 1 REMARK 465 ILE F 2 REMARK 465 SER F 3 REMARK 465 GLU F 4 REMARK 465 SER F 147 REMARK 465 THR F 148 REMARK 465 SER F 149 REMARK 465 GLY F 150 REMARK 465 LYS F 231 REMARK 465 SER F 232 REMARK 465 CYS F 233 REMARK 465 ASP F 234 REMARK 465 LYS F 235 REMARK 465 THR F 236 REMARK 465 HIS F 237 REMARK 465 THR F 238 REMARK 465 SER E 1 REMARK 465 GLU E 214 REMARK 465 CYS E 215 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OH TYR E 37 OE1 GLN E 90 2.03 REMARK 500 OG1 THR A 150 OG SER F 55 2.11 REMARK 500 OG SER A 125 OG SER A 176 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER F 35 147.71 -172.08 REMARK 500 VAL F 51 -63.23 -122.05 REMARK 500 ALA F 95 -176.14 -171.63 REMARK 500 ASP F 161 62.12 63.23 REMARK 500 ASN F 221 50.57 38.05 REMARK 500 SER E 51 -170.29 62.22 REMARK 500 ALA E 145 141.55 -170.26 REMARK 500 ASN E 153 -1.07 71.41 REMARK 500 SER E 160 148.09 -174.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-25177 RELATED DB: EMDB REMARK 900 CRYO-EM STRUCTURE OF ACKR3 IN COMPLEX WITH A SMALL MOLECULE AGONIST, REMARK 900 AND AN INTRACELLULAR FAB. DBREF 7SK9 A 2 362 UNP P25106 ACKR3_HUMAN 2 362 DBREF 7SK9 F 1 238 PDB 7SK9 7SK9 1 238 DBREF 7SK9 E 1 215 PDB 7SK9 7SK9 1 215 SEQADV 7SK9 GLY A -1 UNP P25106 CLONING ARTIFACT SEQADV 7SK9 ALA A 0 UNP P25106 CLONING ARTIFACT SEQADV 7SK9 PRO A 1 UNP P25106 CLONING ARTIFACT SEQADV 7SK9 GLY A 363 UNP P25106 EXPRESSION TAG SEQADV 7SK9 ARG A 364 UNP P25106 EXPRESSION TAG SEQADV 7SK9 PRO A 365 UNP P25106 EXPRESSION TAG SEQADV 7SK9 LEU A 366 UNP P25106 EXPRESSION TAG SEQADV 7SK9 GLU A 367 UNP P25106 EXPRESSION TAG SEQADV 7SK9 VAL A 368 UNP P25106 EXPRESSION TAG SEQADV 7SK9 LEU A 369 UNP P25106 EXPRESSION TAG SEQADV 7SK9 PHE A 370 UNP P25106 EXPRESSION TAG SEQADV 7SK9 GLN A 371 UNP P25106 EXPRESSION TAG SEQADV 7SK9 GLY A 372 UNP P25106 EXPRESSION TAG SEQADV 7SK9 PRO A 373 UNP P25106 EXPRESSION TAG SEQADV 7SK9 HIS A 374 UNP P25106 EXPRESSION TAG SEQADV 7SK9 HIS A 375 UNP P25106 EXPRESSION TAG SEQADV 7SK9 HIS A 376 UNP P25106 EXPRESSION TAG SEQADV 7SK9 HIS A 377 UNP P25106 EXPRESSION TAG SEQADV 7SK9 HIS A 378 UNP P25106 EXPRESSION TAG SEQADV 7SK9 HIS A 379 UNP P25106 EXPRESSION TAG SEQADV 7SK9 HIS A 380 UNP P25106 EXPRESSION TAG SEQADV 7SK9 HIS A 381 UNP P25106 EXPRESSION TAG SEQADV 7SK9 HIS A 382 UNP P25106 EXPRESSION TAG SEQADV 7SK9 HIS A 383 UNP P25106 EXPRESSION TAG SEQADV 7SK9 ASP A 384 UNP P25106 EXPRESSION TAG SEQADV 7SK9 TYR A 385 UNP P25106 EXPRESSION TAG SEQADV 7SK9 LYS A 386 UNP P25106 EXPRESSION TAG SEQADV 7SK9 ASP A 387 UNP P25106 EXPRESSION TAG SEQADV 7SK9 ASP A 388 UNP P25106 EXPRESSION TAG SEQADV 7SK9 ASP A 389 UNP P25106 EXPRESSION TAG SEQADV 7SK9 ASP A 390 UNP P25106 EXPRESSION TAG SEQADV 7SK9 LYS A 391 UNP P25106 EXPRESSION TAG SEQRES 1 A 393 GLY ALA PRO ASP LEU HIS LEU PHE ASP TYR SER GLU PRO SEQRES 2 A 393 GLY ASN PHE SER ASP ILE SER TRP PRO CYS ASN SER SER SEQRES 3 A 393 ASP CYS ILE VAL VAL ASP THR VAL MET CYS PRO ASN MET SEQRES 4 A 393 PRO ASN LYS SER VAL LEU LEU TYR THR LEU SER PHE ILE SEQRES 5 A 393 TYR ILE PHE ILE PHE VAL ILE GLY MET ILE ALA ASN SER SEQRES 6 A 393 VAL VAL VAL TRP VAL ASN ILE GLN ALA LYS THR THR GLY SEQRES 7 A 393 TYR ASP THR HIS CYS TYR ILE LEU ASN LEU ALA ILE ALA SEQRES 8 A 393 ASP LEU TRP VAL VAL LEU THR ILE PRO VAL TRP VAL VAL SEQRES 9 A 393 SER LEU VAL GLN HIS ASN GLN TRP PRO MET GLY GLU LEU SEQRES 10 A 393 THR CYS LYS VAL THR HIS LEU ILE PHE SER ILE ASN LEU SEQRES 11 A 393 PHE GLY SER ILE PHE PHE LEU THR CYS MET SER VAL ASP SEQRES 12 A 393 ARG TYR LEU SER ILE THR TYR PHE THR ASN THR PRO SER SEQRES 13 A 393 SER ARG LYS LYS MET VAL ARG ARG VAL VAL CYS ILE LEU SEQRES 14 A 393 VAL TRP LEU LEU ALA PHE CYS VAL SER LEU PRO ASP THR SEQRES 15 A 393 TYR TYR LEU LYS THR VAL THR SER ALA SER ASN ASN GLU SEQRES 16 A 393 THR TYR CYS ARG SER PHE TYR PRO GLU HIS SER ILE LYS SEQRES 17 A 393 GLU TRP LEU ILE GLY MET GLU LEU VAL SER VAL VAL LEU SEQRES 18 A 393 GLY PHE ALA VAL PRO PHE SER ILE ILE ALA VAL PHE TYR SEQRES 19 A 393 PHE LEU LEU ALA ARG ALA ILE SER ALA SER SER ASP GLN SEQRES 20 A 393 GLU LYS HIS SER SER ARG LYS ILE ILE PHE SER TYR VAL SEQRES 21 A 393 VAL VAL PHE LEU VAL CYS TRP LEU PRO TYR HIS VAL ALA SEQRES 22 A 393 VAL LEU LEU ASP ILE PHE SER ILE LEU HIS TYR ILE PRO SEQRES 23 A 393 PHE THR CYS ARG LEU GLU HIS ALA LEU PHE THR ALA LEU SEQRES 24 A 393 HIS VAL THR GLN CYS LEU SER LEU VAL HIS CYS CYS VAL SEQRES 25 A 393 ASN PRO VAL LEU TYR SER PHE ILE ASN ARG ASN TYR ARG SEQRES 26 A 393 TYR GLU LEU MET LYS ALA PHE ILE PHE LYS TYR SER ALA SEQRES 27 A 393 LYS THR GLY LEU THR LYS LEU ILE ASP ALA SER ARG VAL SEQRES 28 A 393 SER GLU THR GLU TYR SER ALA LEU GLU GLN SER THR LYS SEQRES 29 A 393 GLY ARG PRO LEU GLU VAL LEU PHE GLN GLY PRO HIS HIS SEQRES 30 A 393 HIS HIS HIS HIS HIS HIS HIS HIS ASP TYR LYS ASP ASP SEQRES 31 A 393 ASP ASP LYS SEQRES 1 F 238 GLU ILE SER GLU VAL GLN LEU VAL GLU SER GLY GLY GLY SEQRES 2 F 238 LEU VAL GLN PRO GLY GLY SER LEU ARG LEU SER CYS ALA SEQRES 3 F 238 ALA SER GLY PHE ASN ILE SER SER SER SER ILE HIS TRP SEQRES 4 F 238 VAL ARG GLN ALA PRO GLY LYS GLY LEU GLU TRP VAL ALA SEQRES 5 F 238 SER ILE SER PRO SER TYR GLY TYR THR SER TYR ALA ASP SEQRES 6 F 238 SER VAL LYS GLY ARG PHE THR ILE SER ALA ASP THR SER SEQRES 7 F 238 LYS ASN THR ALA TYR LEU GLN MET ASN SER LEU ARG ALA SEQRES 8 F 238 GLU ASP THR ALA VAL TYR TYR CYS ALA ARG VAL SER TYR SEQRES 9 F 238 TRP ASP TRP THR TRP GLY TRP SER LYS TYR GLU GLY MET SEQRES 10 F 238 ASP TYR TRP GLY GLN GLY THR LEU VAL THR VAL SER SER SEQRES 11 F 238 ALA SER THR LYS GLY PRO SER VAL PHE PRO LEU ALA PRO SEQRES 12 F 238 SER SER LYS SER THR SER GLY GLY THR ALA ALA LEU GLY SEQRES 13 F 238 CYS LEU VAL LYS ASP TYR PHE PRO GLU PRO VAL THR VAL SEQRES 14 F 238 SER TRP ASN SER GLY ALA LEU THR SER GLY VAL HIS THR SEQRES 15 F 238 PHE PRO ALA VAL LEU GLN SER SER GLY LEU TYR SER LEU SEQRES 16 F 238 SER SER VAL VAL THR VAL PRO SER SER SER LEU GLY THR SEQRES 17 F 238 GLN THR TYR ILE CYS ASN VAL ASN HIS LYS PRO SER ASN SEQRES 18 F 238 THR LYS VAL ASP LYS LYS VAL GLU PRO LYS SER CYS ASP SEQRES 19 F 238 LYS THR HIS THR SEQRES 1 E 215 SER ASP ILE GLN MET THR GLN SER PRO SER SER LEU SER SEQRES 2 E 215 ALA SER VAL GLY ASP ARG VAL THR ILE THR CYS ARG ALA SEQRES 3 E 215 SER GLN SER VAL SER SER ALA VAL ALA TRP TYR GLN GLN SEQRES 4 E 215 LYS PRO GLY LYS ALA PRO LYS LEU LEU ILE TYR SER ALA SEQRES 5 E 215 SER SER LEU TYR SER GLY VAL PRO SER ARG PHE SER GLY SEQRES 6 E 215 SER ARG SER GLY THR ASP PHE THR LEU THR ILE SER SER SEQRES 7 E 215 LEU GLN PRO GLU ASP PHE ALA THR TYR TYR CYS GLN GLN SEQRES 8 E 215 SER TYR TYR TYR PRO ILE THR PHE GLY GLN GLY THR LYS SEQRES 9 E 215 VAL GLU ILE LYS ARG THR VAL ALA ALA PRO SER VAL PHE SEQRES 10 E 215 ILE PHE PRO PRO SER ASP SER GLN LEU LYS SER GLY THR SEQRES 11 E 215 ALA SER VAL VAL CYS LEU LEU ASN ASN PHE TYR PRO ARG SEQRES 12 E 215 GLU ALA LYS VAL GLN TRP LYS VAL ASP ASN ALA LEU GLN SEQRES 13 E 215 SER GLY ASN SER GLN GLU SER VAL THR GLU GLN ASP SER SEQRES 14 E 215 LYS ASP SER THR TYR SER LEU SER SER THR LEU THR LEU SEQRES 15 E 215 SER LYS ALA ASP TYR GLU LYS HIS LYS VAL TYR ALA CYS SEQRES 16 E 215 GLU VAL THR HIS GLN GLY LEU SER SER PRO VAL THR LYS SEQRES 17 E 215 SER PHE ASN ARG GLY GLU CYS HET GJ9 A 401 75 HET CLR A 402 74 HET CLR A 403 74 HETNAM GJ9 (1R)-4-[7-(3-CARBOXYPROPOXY)-6-METHYLQUINOLIN-8-YL]-1- HETNAM 2 GJ9 {[2-(4-HYDROXYPIPERIDIN-1-YL)-1,3-THIAZOL-4- HETNAM 3 GJ9 YL]METHYL}-1,4-DIAZEPAN-1-IUM HETNAM CLR CHOLESTEROL FORMUL 4 GJ9 C28 H38 N5 O4 S 1+ FORMUL 5 CLR 2(C27 H46 O) HELIX 1 AA1 LYS A 40 LYS A 73 1 34 HELIX 2 AA2 HIS A 80 GLN A 106 1 27 HELIX 3 AA3 GLY A 113 TYR A 148 1 36 HELIX 4 AA4 PHE A 149 THR A 152 5 4 HELIX 5 AA5 PRO A 153 TYR A 182 1 30 HELIX 6 AA6 SER A 204 LEU A 219 1 16 HELIX 7 AA7 PHE A 221 SER A 242 1 22 HELIX 8 AA8 SER A 243 SER A 249 1 7 HELIX 9 AA9 ILE A 253 LEU A 280 1 28 HELIX 10 AB1 THR A 286 LEU A 305 1 20 HELIX 11 AB2 LEU A 305 VAL A 310 1 6 HELIX 12 AB3 VAL A 310 SER A 316 1 7 HELIX 13 AB4 ASN A 319 ALA A 329 1 11 HELIX 14 AB5 ASN F 31 SER F 35 5 5 HELIX 15 AB6 ASP F 65 LYS F 68 5 4 HELIX 16 AB7 ARG F 90 THR F 94 5 5 HELIX 17 AB8 GLN E 80 PHE E 84 5 5 HELIX 18 AB9 SER E 122 GLY E 129 1 8 HELIX 19 AC1 LYS E 184 HIS E 190 1 7 SHEET 1 AA1 2 TYR A 77 THR A 79 0 SHEET 2 AA1 2 TRP F 111 LYS F 113 -1 O SER F 112 N ASP A 78 SHEET 1 AA2 2 LEU A 183 LYS A 184 0 SHEET 2 AA2 2 ARG A 197 SER A 198 -1 O ARG A 197 N LYS A 184 SHEET 1 AA3 3 SER F 20 ALA F 26 0 SHEET 2 AA3 3 THR F 81 ASN F 87 -1 O ALA F 82 N CYS F 25 SHEET 3 AA3 3 PHE F 71 ASP F 76 -1 N THR F 72 O GLN F 85 SHEET 1 AA4 5 SER F 62 TYR F 63 0 SHEET 2 AA4 5 LEU F 48 ILE F 54 -1 N SER F 53 O SER F 62 SHEET 3 AA4 5 SER F 36 GLN F 42 -1 N ARG F 41 O GLU F 49 SHEET 4 AA4 5 ALA F 95 VAL F 102 -1 O VAL F 102 N SER F 36 SHEET 5 AA4 5 LEU F 125 VAL F 126 -1 O VAL F 126 N ALA F 95 SHEET 1 AA5 4 SER F 137 LEU F 141 0 SHEET 2 AA5 4 THR F 152 TYR F 162 -1 O LEU F 158 N PHE F 139 SHEET 3 AA5 4 TYR F 193 PRO F 202 -1 O VAL F 199 N LEU F 155 SHEET 4 AA5 4 VAL F 180 THR F 182 -1 N HIS F 181 O VAL F 198 SHEET 1 AA6 4 SER F 137 LEU F 141 0 SHEET 2 AA6 4 THR F 152 TYR F 162 -1 O LEU F 158 N PHE F 139 SHEET 3 AA6 4 TYR F 193 PRO F 202 -1 O VAL F 199 N LEU F 155 SHEET 4 AA6 4 VAL F 186 LEU F 187 -1 N VAL F 186 O SER F 194 SHEET 1 AA7 3 THR F 168 TRP F 171 0 SHEET 2 AA7 3 TYR F 211 HIS F 217 -1 O ASN F 214 N SER F 170 SHEET 3 AA7 3 THR F 222 VAL F 228 -1 O VAL F 224 N VAL F 215 SHEET 1 AA8 4 THR E 6 SER E 8 0 SHEET 2 AA8 4 VAL E 20 ARG E 25 -1 O THR E 23 N SER E 8 SHEET 3 AA8 4 ASP E 71 ILE E 76 -1 O PHE E 72 N CYS E 24 SHEET 4 AA8 4 PHE E 63 SER E 68 -1 N SER E 68 O ASP E 71 SHEET 1 AA9 2 SER E 11 SER E 13 0 SHEET 2 AA9 2 LYS E 104 GLU E 106 1 O LYS E 104 N LEU E 12 SHEET 1 AB1 4 SER E 54 LEU E 55 0 SHEET 2 AB1 4 LYS E 46 TYR E 50 -1 N TYR E 50 O SER E 54 SHEET 3 AB1 4 VAL E 34 GLN E 38 -1 N TRP E 36 O ILE E 49 SHEET 4 AB1 4 CYS E 89 GLN E 91 -1 O GLN E 90 N ALA E 35 SHEET 1 AB2 4 SER E 115 PHE E 119 0 SHEET 2 AB2 4 THR E 130 PHE E 140 -1 O VAL E 134 N PHE E 119 SHEET 3 AB2 4 TYR E 174 SER E 183 -1 O LEU E 176 N LEU E 137 SHEET 4 AB2 4 GLN E 161 VAL E 164 -1 N GLN E 161 O THR E 179 SHEET 1 AB3 4 ALA E 154 GLN E 156 0 SHEET 2 AB3 4 LYS E 146 VAL E 151 -1 N VAL E 151 O ALA E 154 SHEET 3 AB3 4 VAL E 192 THR E 198 -1 O GLU E 196 N GLN E 148 SHEET 4 AB3 4 VAL E 206 ASN E 211 -1 O PHE E 210 N TYR E 193 SSBOND 1 CYS A 117 CYS A 196 1555 1555 2.03 SSBOND 2 CYS F 25 CYS F 99 1555 1555 2.04 SSBOND 3 CYS F 157 CYS F 213 1555 1555 2.03 SSBOND 4 CYS E 24 CYS E 89 1555 1555 2.04 SSBOND 5 CYS E 135 CYS E 195 1555 1555 2.03 CISPEP 1 PHE F 163 PRO F 164 0 -4.71 CISPEP 2 GLU F 165 PRO F 166 0 -1.02 CISPEP 3 SER E 8 PRO E 9 0 -6.51 CISPEP 4 TYR E 95 PRO E 96 0 -1.50 CISPEP 5 TYR E 141 PRO E 142 0 3.12 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000